Study in Patients With Advanced Non-Small Cell Lung Cancer Treated With Pemetrexed and Carboplatin Plus or Minus Sorafenib

Stopped Sorafenib administered in the combination with pemetrexed-carboplatin appears to enhance thrombocytopenia compared to historical data.

Conditions

• Carcinoma, Non-Small-Cell Lung

Interventions

• DRUG: pemetrexed, carboplatin, sorafenib
• DRUG: pemetrexed, carboplatin, placebo

Sponsor

University Hospital Muenster

Collaborators

• [object Object]
• [object Object]